Sign Up to like & get
recommendations!
0
Published in 2021 at "Biomolecules"
DOI: 10.3390/biom11040544
Abstract: Antithrombin (AT) is a serine protease inhibitor, its activity is highly accelerated by heparin. Mutations at the heparin-binding region lead to functional defect, type II heparin-binding site (IIHBS) AT deficiency. The aim of this study…
read more here.
Keywords:
silico methods;
differences antithrombin;
heparin binding;
investigation differences ... See more keywords